Oncotarget

August 20, 2019

View Archive »

About The Cover

The cover for issue 49 of Oncotarget features Figure 4, "Meta-analysis of DEGs in SS and L-HES T cells," by Moerman-Herzog, et al.

Table of Contents

Editorial

Mouse models to decipher anti-tumor immunity

Mouse models to decipher anti-tumor immunity

https://doi.org/10.18632/oncotarget.27111

Thomas Parigger, Richard Greil,  and Nadja Zaborsky
5005-5006
PDF  |  How to cite

Research Perspectives

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis

https://doi.org/10.18632/oncotarget.27134

Chong Gao, Gu Xiao,  and Jill Bargonetti
5007-5010
Abstract  |  PDF  |  Full Text  |  How to cite

Research Papers

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer

https://doi.org/10.18632/oncotarget.27082

Nicci Owusu-Brackett, Kurt W. Evans, Argun Akcakanat, Erkan Yuca, Coya Tapia, Yasmeen Qamar Rizvi, Ecaterina Ileana Dumbrava, Filip Janku,  and Funda Meric-Bernstam
5011-5019
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Prognostic value of tumor growth kinetic parameters in prostate cancer patients

Prognostic value of tumor growth kinetic parameters in prostate cancer patients

https://doi.org/10.18632/oncotarget.27088

Gennady M. Zharinov, Oleg A. Bogomolov, Natalia Yu. Neklasova, Grigory A. Raskin, Irina V. Chepurnaya, Sergey N. Bugrov,  and Vladimir N. Anisimov
5020-5027
Abstract  |  PDF  |  Full Text  |  How to cite

Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma

Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma

https://doi.org/10.18632/oncotarget.27096

Jingbo Qiao, Eric J. Rellinger, Kwang Woon Kim, Camille M. Powers, Sora Lee, Hernan Correa,  and Dai H. Chung
5028-5040
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Vascular endothelium function among male carriers of BRCA 1&2 germline mutation

Vascular endothelium function among male carriers of BRCA 1&2 germline mutation

https://doi.org/10.18632/oncotarget.27118

Guy Witberg, Eli Lev, Yaara Ber, Tzlil Tabachnik, Sivan Sela, Ira Belo, Dorit Leshem-Lev,  and David Margel
5041-5051
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes

Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes

https://doi.org/10.18632/oncotarget.27120

Andrea M. Moerman-Herzog, Daniel A. Acheampong, Amanda G. Brooks, Suzan M. Blair, Ping-Ching Hsu,  and Henry K. Wong
5052-5069
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Idiotypic and anti-idiotypic antibodies against polycyclic aromatic hydrocarbon in human blood serum are new biomarkers of lung cancer

Idiotypic and anti-idiotypic antibodies against polycyclic aromatic hydrocarbon in human blood serum are new biomarkers of lung cancer

https://doi.org/10.18632/oncotarget.27126

Ivan S. Grebenshchikov, Artem E. Studennikov, Vadim I. Ivanov, Natalia V. Ivanova, Victor A. Titov, Natalja E. Vergbickaya,  and Valentin A. Ustinov
5070-5081
Abstract  |  PDF  |  Full Text  |  How to cite

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting

https://doi.org/10.18632/oncotarget.27133

Martin Boegemann, Katrin Schlack, Lena Früchtenicht, Julie Steinestel, Andres Jan Schrader, Yvonne Wennmann, Laura-Maria Krabbe,  and Okyaz Eminaga
5082-5091
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma

Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.27149

Kimberly J. Riehle, Heidi L. Kenerson, Kevin M. Riggle, Rigney Turnham, Kevin Sullivan, Renay Bauer, John D. Scott,  and Raymond S. Yeung
5092-5102
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking

https://doi.org/10.18632/oncotarget.27150

Anjan K. Pradhan, Praveen Bhoopathi, Sarmistha Talukdar, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Andrei I. Ivanov,  and Paul B. Fisher
5103-5117
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Corrections

Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

https://doi.org/10.18632/oncotarget.27158

Anna Szewczyk, Julie Gehl, Malgorzata Daczewska, Jolanta Saczko, Stine Krog Frandsen,  and Julita Kulbacka
5118-5118
Correction  |  PDF  |  How to cite

Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue

Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue

https://doi.org/10.18632/oncotarget.27161

Moen Sen, Friedrich Hahn, Taylor A. Black, Maureen DeMarshall, Warren Porter, Eileen Snowden, Stephanie S. Yee, Frances Tong, Mitchell Ferguson, Emylee N. Fleshman, Hiroshi Nakagawa, Gary W. Falk, Gregory G. Ginsberg, Michael L. Kochman, Rainer Blaesius, Anil K. Rustgi,  and Erica L. Carpenter
5119-5119
Correction  |  PDF  |  How to cite

Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo

Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo

https://doi.org/10.18632/oncotarget.27162

Laurence Booth, Jane L. Roberts, Andrew Poklepovic, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani,  and Paul Dent
5120-5122
Correction  |  PDF  |  How to cite

Retraction

Retraction: Deficient for endoplasmic reticulum calcium sensors Stim1 and Stim2 affects aberrant antibody affinity maturation in B cells

Retraction: Deficient for endoplasmic reticulum calcium sensors Stim1 and Stim2 affects aberrant antibody affinity maturation in B cells

https://doi.org/10.18632/oncotarget.27171

Xuhua Mao, Jianfeng Zhang, Yue Han, Chao Luan, Yu Hu, Zhimin Hao,  and Min Chen
5123-5123
Retraction  |  PDF  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC